These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24492291)

  • 1. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.
    Kornberger P; Skerra A
    MAbs; 2014; 6(2):354-66. PubMed ID: 24492291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
    J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
    Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life.
    Schlapschy M; Theobald I; Mack H; Schottelius M; Wester HJ; Skerra A
    Protein Eng Des Sel; 2007 Jun; 20(6):273-84. PubMed ID: 17595342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.
    Cao Y; Marks JW; Liu Z; Cheung LH; Hittelman WN; Rosenblum MG
    Oncogene; 2014 Jan; 33(4):429-39. PubMed ID: 23376850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-directed chimeric toxins created by sortase-mediated protein fusion.
    McCluskey AJ; Collier RJ
    Mol Cancer Ther; 2013 Oct; 12(10):2273-81. PubMed ID: 23945077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.
    Mendler CT; Friedrich L; Laitinen I; Schlapschy M; Schwaiger M; Wester HJ; Skerra A
    MAbs; 2015; 7(1):96-109. PubMed ID: 25484039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of non-specific toxicity of immunotoxin by intein mediated reconstitution on target cells.
    Wang J; Han L; Chen J; Xie Y; Jiang H; Zhu J
    Int Immunopharmacol; 2019 Jan; 66():288-295. PubMed ID: 30502650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
    Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
    ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.
    Zhou X; Qiu J; Wang Z; Huang N; Li X; Li Q; Zhang Y; Zhao C; Luo C; Zhang N; Teng X; Chen Z; Liu X; Yu X; Wu W; Wei YQ; Li J
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1081-90. PubMed ID: 22392077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
    Mujoo K; Reisfeld RA; Cheung L; Rosenblum MG
    Cancer Immunol Immunother; 1991; 34(3):198-204. PubMed ID: 1756537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of alternative nucleophiles for Sortase A-mediated bioconjugation and application in neuronal cell labelling.
    Baer S; Nigro J; Madej MP; Nisbet RM; Suryadinata R; Coia G; Hong LP; Adams TE; Williams CC; Nuttall SD
    Org Biomol Chem; 2014 May; 12(17):2675-85. PubMed ID: 24643508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin.
    Chen P; Bordeau BM; Zhang Y; Balthasar JP
    Mol Cancer Ther; 2022 Oct; 21(10):1573-1582. PubMed ID: 35930739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors.
    Zhou H; Hittelman WN; Yagita H; Cheung LH; Martin SS; Winkles JA; Rosenblum MG
    Cancer Res; 2013 Jul; 73(14):4439-50. PubMed ID: 23722548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
    Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
    Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective formation of covalent protein heterodimers with an unnatural amino acid.
    Hutchins BM; Kazane SA; Staflin K; Forsyth JS; Felding-Habermann B; Smider VV; Schultz PG
    Chem Biol; 2011 Mar; 18(3):299-303. PubMed ID: 21439474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bispecific Antibody Based on Pertuzumab Fab Has Potent Antitumor Activity.
    Deng W; Liu J; Pan H; Li L; Zhou C; Wang X; Shu R; Dong B; Cao D; Li Q; Wang Z
    J Immunother; 2018 Jan; 41(1):1-8. PubMed ID: 29232309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
    Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
    Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.